Skip to content

Zymeworks ZYME EV / sales

EV / sales at other companies

Pfizer logo
PfizerPFE
3.5×+0.3×
Amgen logo
AmgenAMGN
6.6×+0.1×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
5.8×+1.4×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
26.2×-3,303×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
13.8×-9.9×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
55.3×+54.8×

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on the most recent quarter.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's EV / sales?
Zymeworks (ZYME) reported EV / sales of 20.1× in Q1 2026.
How has Zymeworks's EV / sales changed year-over-year?
Zymeworks's EV / sales increased by 143.5% year-over-year, from 8.3× to 20.1×.
What is the long-term trend for Zymeworks's EV / sales?
Over 3 years (2022 to 2025), Zymeworks's EV / sales has grown at a 296.7% compound annual growth rate (CAGR), from 0.3× to 18.5×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.